The clinical use of G-CSF has been explored in numerous disease states, such as to stimulate the production of neutrophils in chemotherapy-related neutropenia and to mobilize hematopoietic stem cells from the bone marrow into the blood to enhance the safety and efficacy of hematopoietic stem cell transplantation [27]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.